Pyxis Oncology Inc. (PYXS) NASDAQ
$4.15 (0.02) (-0.48%)
Market Cap: $244.39M
As of 05/17/24 04:00 PM EDT. Market closed.
Pyxis Oncology Inc. (PYXS)
NASDAQ
$4.15
(0.02) (-0.48%)
Market Cap: $244.39M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
70
Address
.
PRICE CHART FOR PYXIS ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.10
Previous Close
$4.17
Days Range
$4.11 - $4.26
52 week range
$1.35 - $6.85
Volume
257,383
Avg. Volume (30 days)
390,354
Market Cap
$244.39M
Dividend Yield
-
P/E
-
Shares Outstanding
58,888,473
Open
$4.10
Previous Close
$4.17
Days Range
$4.11 - $4.26
52 week range
$1.35 - $6.85
Volume
257,383
Avg. Volume (30 days)
390,354
Market Cap
$244.39M
Dividend Yield
-
P/E
-
Shares Outstanding
58,888,473
FINANCIAL STATEMENTS FOR PYXIS ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PYXIS ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Connealy Pamela Ann | CFO and COO | Nov 29, 2023 | Option Exercise | $1.40 | 36,949 | 51,729 | 781,583 | Nov 30, 2023, 04:15 PM |
| Connealy Pamela Ann | CFO and COO | Sep 28, 2023 | Buy | $1.87 | 8,000 | 14,960 | 818,532 | Sep 28, 2023, 04:32 PM |
| Wadhane Jitendra | Chief Accounting Officer | Sep 27, 2023 | Buy | $1.87 | 2,500 | 4,675 | 226,937 | Sep 27, 2023, 06:37 PM |
| Connealy Pamela Ann | CFO and COO | Sep 27, 2023 | Buy | $1.85 | 6,426 | 11,868 | 810,532 | Sep 27, 2023, 06:36 PM |
| Wadhane Jitendra | Chief Accounting Officer | Sep 25, 2023 | Buy | $1.77 | 5,000 | 8,850 | 224,437 | Sep 25, 2023, 05:05 PM |
| Connealy Pamela Ann | CFO and COO | Sep 25, 2023 | Buy | $1.67 | 12,000 | 20,044 | 804,106 | Sep 25, 2023, 05:04 PM |
| Wadhane Jitendra | Chief Accounting Officer | Sep 22, 2023 | Buy | $1.74 | 2,500 | 4,349 | 219,437 | Sep 22, 2023, 07:35 PM |
| Connealy Pamela Ann | CFO and COO | Sep 22, 2023 | Buy | $1.74 | 5,000 | 8,695 | 792,106 | Sep 22, 2023, 07:34 PM |
| Sullivan Lara | President and CEO | Sep 18, 2023 | Sale | $2.10 | 8,541 | 17,936 | 2,403,882 | Sep 18, 2023, 07:03 PM |
| Sullivan Lara | President and CEO | Sep 14, 2023 | Sale | $2.25 | 100 | 225 | 2,412,423 | Sep 18, 2023, 07:03 PM |
| Sullivan Lara | President and CEO | Sep 13, 2023 | Option Exercise | $2.13 | 184,742 | 393,500 | 2,412,523 | Sep 13, 2023, 08:16 PM |
| Sullivan Lara | President and CEO | Sep 13, 2023 | Sale | $2.27 | 3,000 | 6,816 | 2,597,265 | Sep 13, 2023, 08:16 PM |
| Sullivan Lara | President and CEO | Sep 12, 2023 | Sale | $2.25 | 4,917 | 11,071 | 2,600,265 | Sep 13, 2023, 08:16 PM |
| Sullivan Lara | President and CEO | Sep 11, 2023 | Sale | $2.27 | 20,000 | 45,414 | 2,605,182 | Sep 13, 2023, 08:16 PM |
| PFIZER INC | 10% Owner | Mar 17, 2023 | Buy | $2.76 | 1,811,594 | 4,999,999 | 5,952,263 | Mar 23, 2023, 04:14 PM |
| PFIZER INC | 10% Owner | Mar 17, 2023 | Buy | $2.76 | 1,811,594 | 4,999,999 | 5,952,263 | Mar 21, 2023, 06:07 PM |
| Chin Mark | Former Director | Apr 21, 2022 | Sale | $3.05 | 1,745,761 | 5,324,571 | 0 | Apr 25, 2022, 12:12 PM |
| Cline Darren S | Director | Dec 08, 2021 | Buy | $9.39 | 10,000 | 93,885 | 10,000 | Dec 09, 2021, 04:18 PM |
| Civik Thomas | Director | Nov 18, 2021 | Buy | $12.74 | 15,700 | 200,018 | 15,700 | Nov 19, 2021, 01:21 PM |
| Chin Mark | Director | Oct 13, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 1,745,761 | Oct 15, 2021, 05:37 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Oct 13, 2021 | Buy | $16.00 | 450,000 | 7,200,000 | 1,118,854 | Oct 15, 2021, 04:12 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Connealy Pamela Ann | CFO and COO | 11/29/2023 | 51,729 |
| Connealy Pamela Ann | CFO and COO | 09/28/2023 | 14,960 |
| Wadhane Jitendra | Chief Accounting Officer | 09/27/2023 | 4,675 |
| Connealy Pamela Ann | CFO and COO | 09/27/2023 | 11,868 |
| Wadhane Jitendra | Chief Accounting Officer | 09/25/2023 | 8,850 |
| Connealy Pamela Ann | CFO and COO | 09/25/2023 | 20,044 |
| Wadhane Jitendra | Chief Accounting Officer | 09/22/2023 | 4,349 |
| Connealy Pamela Ann | CFO and COO | 09/22/2023 | 8,695 |
| Sullivan Lara | President and CEO | 09/18/2023 | 17,936 |
| Sullivan Lara | President and CEO | 09/14/2023 | 225 |
| Sullivan Lara | President and CEO | 09/13/2023 | 393,500 |
| Sullivan Lara | President and CEO | 09/13/2023 | 6,816 |
| Sullivan Lara | President and CEO | 09/12/2023 | 11,071 |
| Sullivan Lara | President and CEO | 09/11/2023 | 45,414 |
| PFIZER INC | 10% Owner | 03/17/2023 | 4,999,999 |
| PFIZER INC | 10% Owner | 03/17/2023 | 4,999,999 |
| Chin Mark | Former Director | 04/21/2022 | 5,324,571 |
| Cline Darren S | Director | 12/08/2021 | 93,885 |
| Civik Thomas | Director | 11/18/2021 | 200,018 |
| Chin Mark | Director | 10/13/2021 | 5,000,000 |
| Cormorant Asset Management, LP | Former 10% Owner | 10/13/2021 | 7,200,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PYXIS ONCOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 2,594,324 | 0.02% | New | Event Driven |
| HHLR ADVISORS, LTD. | 382,606 | 0.04% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 148,000 | 0.00099% | -59.36% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 340,121 | 0.00013% | 10.34% | Other |
| BLACKROCK INC. | 321,665 | 0.00003% | 3.56% | Other |
CHANGE IN SHARES OUTSTANDING FOR PYXIS ONCOLOGY INC
STOCK BUYBACKS FOR PYXIS ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
15.31%
1Q
09/30/2023
24.09%
2Q
06/30/2023
33.60%
3Q
03/31/2023
45.08%
4Q
12/31/2022
47.38%
5Q
09/30/2022
57.52%
6Q
06/30/2022
58.05%
7Q
03/31/2022
58.71%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PYXIS ONCOLOGY INC
LOADING...